Matthew J. Weiss

Matthew J. Weiss

Auto-generated profile, based on publicly available information

Matthew J. Weiss

Department of Surgery, Cancer Institute, Northwell Health, NY, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2025 in HPB
Verified
Journal Article
Closed access
AAAbdullah Altaf
Abdullah Altaf
MAMiho Akabane
Miho Akabane
MKMujtaba Khalil
Mujtaba Khalil
ZRZayed Rashid
Zayed Rashid
SZShahzaib Zindani
Shahzaib Zindani
Tim PawlikTim Pawlik
Tim Pawlik

29 April 2025 in HPB
Verified
Journal Article
Closed access
ZRZayed Rashid
Zayed Rashid
AAAbdullah Altaf
Abdullah Altaf
MKMujtaba Khalil
Mujtaba Khalil
GCGiovanni Catalano
Giovanni Catalano
SZShahzaib Zindani
Shahzaib Zindani
Tim PawlikTim Pawlik
Tim Pawlik

20 October 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
OCOdysseas P. Chatzipanagiotou
Odysseas P. Chatzipanagiotou
JKJun Kawashima
Jun Kawashima
ABAndrea Baldo
Andrea Baldo
ARAndrea Ruzzenente
Andrea Ruzzenente
GPGeorge A. Poultsides
George A. Poultsides
Tim PawlikTim Pawlik
Tim Pawlik

19 March 2026 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
KYKizuki Yuza
Kizuki Yuza
JKJun Kawashima
Jun Kawashima
OCOdysseas P. Chatzipanagiotou
Odysseas P. Chatzipanagiotou
CHChristian Hobeika
Christian Hobeika
FAFederico Aucejo
Federico Aucejo
Tim PawlikTim Pawlik
Tim Pawlik
The prognostic impact of vascular resection in intrahepatic cholangiocarcinoma (iCCA) remains uncertain, particularly in the context of advanced disease requiring complex surgery. This study evaluated the association between vascular resection and long-term survival and examined how tumor biology, assessed with tumor burden score (TBS) and CA19-9, influenced outcomes. Patients who underwent upfront curative-intent hepatectomy for iCCA were identified from an international multi-institutional database. Multivariable Cox regression assessed overall (OS) and recurrence-free survival (RFS). Among patients undergoing vascular resection, biologic heterogeneity was explored using optimized TBS and CA19-9 cutoffs to define biologic risk subgroups. Among 1757 patients, 9.7% (n = 171) required major vascular resection. These patients were more likely to have bilateral tumors (29.2% vs. 21.3%), lymph node metastasis (33.9% vs. 24.8%), and T3/T4 tumors (57.3% vs. 27.6%) (all p < 0.05). Vascular resection was not an independent predictor of OS (aHR 1.11, 95% CI 0.82-1.51) or RFS (HR 1.02, 95% CI 0.81-1.27). Within the vascular resection cohort, higher TBS (aHR 1.11, 95% CI 1.03-1.19) and higher CA19-9 (log-transformed; aHR 1.16, 95% CI 1.02-1.32) were independently associated with worse OS. Five-year survival decreased stepwise from favorable to unfavorable biologic profiles. Patients with favorable biology demonstrated survival comparable to individuals undergoing hepatectomy without vascular resection. Major vascular resection did not independently worsen prognosis after iCCA hepatectomy. Instead, tumor biology-captured by TBS and CA19-9-was strongly associated with long-term outcomes, highlighting the importance of biologic risk stratification when considering vascular resection.

5 December 2025 in HPB
Verified
Journal Article
Closed access
OCOdysseas P. Chatzipanagiotou
Odysseas P. Chatzipanagiotou
GCGiovanni Catalano
Giovanni Catalano
KMKhalil Mujtaba
Khalil Mujtaba
JKJun Kawashima
Jun Kawashima
AAAbdullah Altaf
Abdullah Altaf
Tim PawlikTim Pawlik
Tim Pawlik

4 June 2026 in HPB
Verified
Journal Article
Open access
KYKizuki Yuza
Kizuki Yuza
JKJun Kawashima
Jun Kawashima
Christian HobeikaChristian Hobeika
Christian Hobeika
MLMickael Lesurtel
Mickael Lesurtel
FAFederico Aucejo
Federico Aucejo
Tim PawlikTim Pawlik
Tim Pawlik
Accurate preoperative risk stratification remains essential for patients undergoing curative-intent hepatectomy for intrahepatic cholangiocarcinoma (iCCA) or hepatocellular carcinoma (HCC). Although the albumin-bilirubin (ALBI) score and AST-to-platelet ratio index (APRI) reflect hepatic reserve and fibrosis burden, respectively, their complementary value for predicting liver-related complications across primary liver malignancies remains poorly defined. A retrospective multi-institutional cohort study included 2668 patients who underwent curative-intent hepatic resection for iCCA or HCC (2000-2023). Multivariable logistic regression evaluated associations of ALBI and APRI with liver-related complications, post-hepatectomy liver failure (PHLF), and major complications. Discrimination was assessed using the area under the receiver operating characteristic curve (AUC) with bootstrap internal validation. Among 2668 patients, 392 (14.7%) developed liver-related complications. Both ALBI (OR 1.65, 95% CI 1.28-2.12) and APRI (OR 1.18, 95% CI 1.05-1.33) were independently associated with liver-related complications. The combined model achieved an AUC of 0.740 (optimism-corrected 0.733). ALBI and APRI also demonstrated differential associations across endpoints, with APRI more strongly associated with PHLF and ALBI more strongly associated with major complications. Preoperative ALBI and APRI were independently associated with liver-related complications after hepatectomy for iCCA and HCC, reflecting hepatic reserve and fibrosis-related injury.